http://www.corpwatch.org/article.php?id=11243"That's significant because potassium iodide can help protect against thyroid cancer in the event of exposure to large amounts of radiation -- from a small, easily transported nuclear weapon, say, or a terrorist attack on a nuclear power plant."
.
.
.
"This much at least is clear: If a "nuclear incident," as the bioterror law quaintly puts it, should occur, MedPointe and the Carlyle Group would be uniquely positioned to benefit from catastrophe. That's not danger-mongering. That's a fact.
(For what it's worth, the New York Times reported Friday that government officials have quietly revived a cold-war program for rapidly analyzing fallout from a nuclear attack on U.S. soil. The program is intended to determine the perpetrator of an attack and help coordinate a military response.)
Bechtel might make a convenient target for protesters seeking a high-profile recipient of Iraq-reconstruction dollars. "It's all about capitalism," one masked protester, a self-styled anarchist, told me outside the company's headquarters.
But to find a company truly poised to profit from the unthinkable, he might want to make his way next time to the Transamerica Pyramid. That's where Carlyle's San Francisco office is located."
---------------------
They own the pill to protect against thyroid cancer from radiation.